Therapy Tip
|
|
The
Benicar dose and schedule may be adjusted up or down to control symptoms but a dose must be taken at least every
8 hours to maintain the blockade.
|
CIR Library Access
|
|
Every patient enrolled in CIR's nurse counseling service has access to our extensive library about inflammation therapy.
Anyone wishing to access our library without enrolling in our nurse counseling service should email us. We will require your physician's contact information. A donation of $25 annually is suggested.
|
Know Someone Who Would Enjoy Our Newsletter? |
| Please give your interested friends our website URL and tell them they can register for our newsletter online using the link on our home page. They will need to enter (minimally) their first name and email address. They will be able to unsubscribe at any time. You may also use the "Forward email" link at the bottom left-hand side of this page to send a friend this edition of the newsletter. They can then enroll for our newsletter using the link box below.
|
Join Our List
|
|
Donate Online
Use our secure page to make online donations using Discover, Mastercard, Visa or American Express.
|
|
|
|
Greetings!
We hope you're enjoying the many delights of the holiday season.
This is a joyful time, but it can also be stressful. Chronic Illness Recovery is happy to be able to help busy physicians by counseling their patients about inflammation therapy. Chronically ill patients may find the holidays more stressful than joyful, as they struggle to cope with their illness and the challenging recovery process. CIR is gratified to be able to offer our patients the advice and encouragement they need to cope.
As the New Year approaches and you count your
blessings, we hope that CIR is among them. Let us all look forward to a new year full of positive changes.
Warm regards,
Meg Mangin and Belinda Fenter
|
Getting to Know You
|
Meet Belinda Fenter
Belinda Fenter, who was instrumental in organizing Chronic Illness Recovery as a nonprofit organization, also serves on the Board of Directors and as secretary-treasurer. In addition to those duties, Belinda enjoys working on the CIR monthly newsletter and managing the email database.
"There is so much to do simply to keep a nonprofit organization working," Belinda said. "The volunteers at CIR are such a skilled, wonderful group of people that I feel privileged to work with them. We all know this is a unique outreach, as our nurses are the first to work directly with physicians and their patients using inflammation therapy, as an integrated part of the medical team."
Asked what motivates her involvement at CIR, Belinda responded, "As a member of the Research Team that originally researched and developed inflammation therapy (IT), I was involved from the beginning. Ultimately, once I had experienced this therapy first-hand and regained my own health, there was no way I could simply go back to normal living without ensuring other patients have the option of exploring this intervention. It's heartwarming to reach additional medical professionals and observe on our forum as IT changes the lives of their patients over time."
|
About Inflammation Therapy
|
During 2002-2008,
a unique treatment was developed to treat chronic, degenerative inflammatory
diseases thought to be due to immune system dysfunction caused by persistent,
intracellular bacteria. Based on anecdotal reports, this inflammation
therapy (IT) is showing a high response and recovery rate.
The first
aspect of IT is the use of Benicar (olmesartan medoxomil), an Angiotensin Receptor
Blocker (ARB) at regular intervals. This drug reduces the level of the active
form of vitamin D (1,25-dihydroxyvitamin-D), thus apparently improving immune
system function so the bacteria are eliminated and also providing a partial
anti-inflammatory blockade to reduce symptoms of inflammation.
The second
aspect is the use of a select group of antibiotics at specific doses, intervals
and combinations which is believed to weaken intracellular bacteria by
blocking protein synthesis associated with bacterial reproduction. This makes
it easier for the immune system to kill the bacteria.
The third
aspect is the avoidance of foods and supplements containing natural and
manufactured vitamin D to reduce the level of 25-D (the less active form of
vitamin D) to help restore immune system function. 25-D is thought to displace
the active metabolite from the Vitamin D Receptor in the nucleus of the cell
and prevent normal immune system function.
It's also
necessary for most patients to avoid exposure to natural light falling on the
skin to prevent symptoms caused by production of vitamin D, and to avoid bright
artificial light falling on the eyes which can also increase symptoms.
The hallmark of an effective IT response is an intermittent
increase in symptoms due to bacterial die-off, which occurs in a waxing and
waning pattern (Herxheimer reaction) before eventual, gradual resolution
of symptoms.
IT is a proactive therapy. Patients, or their caregivers,
are expected to learn assessment and management techniques, including
assessing medication response, to help their physician keep symptoms tolerable
during the recovery process.
|
Medical Journal Article
|
Effect of Olmesartan Medoxomil on Atherosclerosis: Clinical Implications of the Emerging Evidence
Authors: S Takai and M Miyazaki Journal: American Journal of Cardiovascular Drugs Issue, Volume and Page: 2006;6(6):363-6 PubMed ID: 17192125
"(O)lmesartan medoxomil, which
rapidly reduces inflammatory markers, may have a beneficial antiatherosclerotic
effect."
|
Quotable Quotes
|
Client Comments
"I'm getting a lot out of this service, as the info y'all
provide is helping to clarify quite a few of my uncertainties. Thanks much."
~ Horse187
"It's nice to see all the new members... just think of all the
people who will be getting the help they need. I'm very happy to see the CIR grow
so quickly." ~ Jean
|
|
About Chronic Illness Recovery
Because
our mission as a non-profit organization is to inform physicians about inflammation therapy, all CIR
resources are available to them free of charge.
Fees are waived for those patients enrolling in our counseling program who are also the first patient their doctor
authorizes for counseling.
All other patients are offered a discounted fee
schedule that is based upon ability to pay. Patients must qualify for a fee reduction.
As a non-profit organization, we provide professional services at a significantly charitable rate. Our full monthly fee for nurse counseling is $75 per patient, which is an effective market-value discount of 42 percent for these professional services.
CIR policy mandates that at least 50% of
our caseload will be patients whose fees have been waived. While we would like to waive all fees, they are necessary to allow us to offset the cost of maintaining a high-quality, professional service. |
|
|